Azacitidin Sandoz 100 mg, Pulver zur Herstellung einer Injektionssuspension - Swissmedic Key 67433001 Registration Holder Sandoz Pharmaceuticals AG Name Azacitidin Sandoz 100 mg, Pulver zur Herstellung einer Injektionssuspension Date of registration 20.05.2020 Original/Generic Generic Introduction of Sequence 20.05.2020 ATC-Classification Azacitidine (L01BC07) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.16.10. Show package size Index Therapeuticus (Swissmedic) 07.16.10. Description Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 224.25 Limitation Yes Limitation text
Deductible 10 % Consumer price 259.95 Feedback FB GTIN 7680674330011 Medication Code Synthetika Pharmacode Disponibility
Composition azacitidinum 100 mg, mannitolum, pro vitro. Packungsbestandteile Galenic Form Powder for injection suspension Excipiens Active Agent Dose Azacitidine 100 mg
BAG: Active Agent Dose Azacitidine 100 mg
Source Data was imported : 06.11.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
